Sanofi has agreed to buy US-based Principia Biopharma for $3.68 billion, strengthening its pipeline of treatments for autoimmune disorders. The deal gives the French...
Lagging behind other big names of late in announcing Covid-19 vaccine supply deals, French and British drugmakers Sanofi and GlaxoSmithkline together nailed down...
European officials recently began talking to companies developing Covid-19 vaccines about supplying the EU’s 27 member states, in hope that none would fall behind bigger...
The UK will not participate in a plan to distribute a potential coronavirus vaccine to Europe’s most vulnerable citizens first. Tim Barrow, the UK’s ambassador to the EU...
Sanofi Pasteur, the vaccines global business unit of French drugmaker Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, are formally...
19.06.2020
- Pressed for production resources due to its effort to develop a vaccine to prevent Covid-19, Sanofi said it will build a new vaccine manufacturing facility at Neuville sur Saône...
15.05.2020
- Former head of GlaxoSmithKline's (GSK) vaccines division, Moncef Slaoui, has been named to lead the so-called "warp speed" effort to develop a coronavirus vaccine announced by US...
Sanofi has urged the EU to create an equivalent of the US government’s Biomedical Advanced Research and Development Authority (BARDA) to coordinate research into a Covid...
